Corning Incorporated vs Illumina, Inc. — how do they compare? Corning Incorporated trades at $152.1 (market cap $131.65B), while Illumina, Inc. trades at $274 (market cap $39.95B). The key difference: Corning Incorporated is far larger — about 3.3× Illumina, Inc.'s market cap, and Corning Incorporated pays a 0.73% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 35 Days and Illumina, Inc. for 83 Days on average.
| GLW | ILMN | |
|---|---|---|
Market Cap | $131.65B | $39.95B |
Volume | 8,992,522 | 3,169,503 |
Sector | Technology | Health |
52-Week High | $255.79 | $293.69 |
52-Week Low | $78.03 | $91.00 |
Typical Hold Time | 35 Days | 83 Days |
Enterprise Value | $138.52B | $41.31B |
Dividend Yield | 0.73% | — |
Signals from Pluang's Aura AI — not financial advice
GLW trades at $163.21, down 3.41% today, with a bullish technical signal and strong analyst support (56.75% buy ratings). Recent fundamentals show robust revenue growth to $15.63B in 2025 and net income of $1.60B, though valuation ratios like P/E of 70.43 appear elevated. The company secured a significant $3B+ fiber supply deal with AT&T, driving positive sentiment amid AI infrastructure demand.
Outlook is positive with earnings beats and a consensus price target of $171.25 offering ~5% upside. Key risks include high debt levels, patent litigation, and sensitivity to tech spending cycles. Institutional confidence remains high given operational cash flow strength and strategic positioning in fiber optics.
Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.
Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →